WELIREG

Identification of Welireg

No description

Google image searchProduct monograph

Active ingredient

belzutifan, 40 MG

DIN: 02528908

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: MERCK CANADA INC

Date: 01-SEP-2022

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
• L01XX — Other antineoplastic agents (ATC, ATC/DDD)
• L01XX74 — BELZUTIFAN (ATC/DDD)

External Links for Welireg

Search on Google

• Welireg side effects
• Welireg dosage
• belzutifan side effects
• belzutifan dosage

Merck Canada Inc

Go to Merck website to see drug product details. Sometimes you can find welireg photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.